School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, China.
School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 100029, China.
BMC Complement Med Ther. 2021 Jun 25;21(1):175. doi: 10.1186/s12906-021-03350-x.
Plantaginis Semen has been widely used as folk medicine and health care food against hyperuricemia (HUA) and gout, but its pharmacological mechanism remains unclear. This study investigated the therapeutic mechanism of Plantaginis Semen extract on potassium oxonate -induced HUA rats based on a lipidomics approach.
A model of HUA was established by potassium oxonate intragastric administration. 42 Sprague-Dawley (SD) male rats were randomly divided into the control group, model group, benzbromarone group (10 mg/kg) and three Plantaginis Semen groups (n = 7). The Plantaginis Semen groups were treated orally with Plantaginis Semen, 0.9375, 1.875 or 3.75 g/kg for 28 days. The levels of serum uric acid (UA), creatinine (Cr), triacylglycerol (TG) and tumor necrosis factor-α (TNF-α) were measured using enzyme-linked immunosorbent assay kits. Ultra performance liquid chromatography quadrupole time of flight mass spectrometry (UPLC-Q-TOF/MS) was used for the serum lipidomics analysis, multivariate statistical analysis and independent samples t-test were carried out for the pattern recognition and characteristic metabolites identification. The relative levels of critical regulatory factors were determined by quantitative real-time polymerase chain reaction (RT-qPCR).
Compared with the model group, the levels of serum UA, Cr, TG and TNF-α were significantly (p < 0.05) decreased in benzbromarone and three Plantaginis Semen groups. With lipidomics analysis, significant lipid metabolic perturbations were observed in HUA rats, 13 metabolites were identified as potential biomarkers and glycerophospholipid metabolism pathway was most affected. These perturbations were partially restored via treatment of benzbromarone and Plantaginis Semen. Additionally, the mRNA expression levels of urate anion transporter 1 (URAT1) and phosphatidylinositol 3-kinase/protein kinases B (PI3K/Akt) were significantly decreased (p < 0.01) after treatment with benzbromarone and high dose of Plantaginis Semen.
Plantaginis Semen had significant effects on anti-HUA, anti-inflammatory and renal protection. It attenuated potassium oxonate-induced HUA through regulation of lipid metabolism disorder.
车前子作为一种民间药物和保健品,被广泛用于治疗高尿酸血症(HUA)和痛风,但它的药理机制尚不清楚。本研究采用脂质组学方法探讨车前子提取物对氧嗪酸钾诱导的 HUA 大鼠的治疗机制。
采用氧嗪酸钾灌胃建立 HUA 模型。42 只雄性 Sprague-Dawley(SD)大鼠随机分为对照组、模型组、苯溴马隆组(10mg/kg)和车前子低、中、高剂量组(n=7)。车前子低、中、高剂量组分别灌胃给予车前子 0.9375、1.875 和 3.75g/kg,连续 28d。采用酶联免疫吸附试验试剂盒检测血清尿酸(UA)、肌酐(Cr)、三酰甘油(TG)和肿瘤坏死因子-α(TNF-α)水平。采用超高效液相色谱四极杆飞行时间质谱(UPLC-Q-TOF/MS)进行血清脂质组学分析,采用多元统计分析和独立样本 t 检验进行模式识别和特征代谢物鉴定。采用实时荧光定量聚合酶链反应(RT-qPCR)测定关键调节因子的相对水平。
与模型组比较,苯溴马隆组和车前子低、中、高剂量组血清 UA、Cr、TG 和 TNF-α水平均显著降低(p<0.05)。脂质组学分析显示,HUA 大鼠存在明显的脂质代谢紊乱,鉴定出 13 个潜在的生物标志物,其中甘油磷脂代谢途径受影响最大。苯溴马隆和车前子可部分改善这些紊乱。此外,苯溴马隆和高剂量车前子治疗后尿酸阴离子转运体 1(URAT1)和磷酸肌醇 3-激酶/蛋白激酶 B(PI3K/Akt)mRNA 表达水平显著降低(p<0.01)。
车前子具有显著的抗 HUA、抗炎和肾脏保护作用。它通过调节脂质代谢紊乱减轻氧嗪酸钾诱导的 HUA。